DL-Xylose [25990-60-7]
Cat# NB-64-00170-1mL
Size : 1mLx10mM(inDMSO)
Brand : Neo Biotech
DL-Xylose (Synonyms: Xylose, (±)-Xylose, (±)-Xylos)
Catalog No. T0032 Copy Product Info
Purity: 99.72%
DL-Xylose ((±)-Xylos) is a sugar first derived from wood. DL-Xylose is classified as a monosaccharide of the aldopentose type.
Select Batch
Purity:99.72%
Appearance:Solid
Color:White
Contact us for more batch information
Product Introduction
DL-Xylose AI Summary
DL-Xylose exhibits antiviral activity, notably against SARS-CoV-2. It has demonstrated inhibition of SARS-CoV-2 induced cytotoxicity in both Caco-2 and VERO-6 cells, with an inhibition rate of -1.82% and -0.18% respectively, at a concentration of 10 µM after 48 hours. Additionally, the compound shows 7.036% inhibition of SARS-CoV-2 3CL-Pro protease at 20 µM, as determined through a FRET assay. Furthermore, DL-Xylose inhibits human HDAC6, reducing enzymatic activity by -8.48% with a commercial peptide substrate and by 0.67% with a custom peptide substrate..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | DL-Xylose ((±)-Xylos) is a sugar first derived from wood. DL-Xylose is classified as a monosaccharide of the aldopentose type. |
| Synonyms | Xylose, (±)-Xylose, (±)-Xylos |
| Molecular Weight | 150.13 |
| Formula | C5H10O5 |
| Cas No. | 25990-60-7 |
| Smiles | [C@H]([C@@H](CO)O)([C@H](C=O)O)O |
| Relative Density. | 1.757g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (333.04 mM), Sonication is recommended. ![]() H2O: 199.8 mM, Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
H2O/DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||



